Clinical Trial Update: Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC) [Phase 2]

View source ↗

Summary

A Phase 2 trial (TEAM PC) is evaluating talazoparib in combination with enzalutamide after progression on abiraterone in metastatic prostate cancer; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Talazoparib (talazoparib)

Snippet

Sponsor: Fundacion Oncosur | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: RECRUITING